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ABSTRACT
A majority of American adults in today’s society are treated for anxiety with
anti-anxiety medications. Some of these prescribed drugs are neither efficiently
metabolized by the human body nor removed by wastewater treatment plants
before they reach streams and rivers and so are often detected in the aquatic
environment in trace concentrations. Once present in surface waters, they have
the potential to cause adverse effects for aquatic organisms, including changes
in both behavior and brain chemistry. Previous work has shown that upon
exposure to 150µg/L fluoxetine, a selective serotonin reuptake inhibitor
antidepressant, hybrid striped bass (M. saxatilis x M. chrysops) brain serotonin
levels decreased by almost 50% over six days. This previous study also
correlated reduced brain serotonin levels with behavioral alterations that
decreased an organism’s ecological fitness, specifically the ability of the
organism to capture its prey. Similarly, other studies have suggested that
fluoxetine, along with other anti-anxiety medications, including diazepam and
buspirone, has the ability to alter an organism’s anxiety behaviors. However,
these studies failed to correlate the alteration in behavior with changes in brain
neurotransmitter levels. While anxiety medications are designed to alter brain
neurotransmitter levels, other investigators have suggested that other
contaminants such as metals can also affect brain chemistry. A previous study
has shown that carp exposed to sub-lethal levels of copper over the course of
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one week experienced decreased brain serotonin levels in three different parts of
the brain.
The current study characterized the effects of ethanol (positive control),
fluoxetine, diazepam, buspirone, and copper exposure on brain chemistry and
behavior in the fathead minnow (Pimephales promelas) using the standard lightdark anxiety behavioral bioassay. At the onset of the experiment, minnows
exposed to ethanol, fluoxetine, and copper for one day displayed anxiolytic
behaviors at lower concentrations. Longer exposures to buspirone and
diazepam also elicited anxiolytic behaviors. Significant decreases in
neurotransmitter levels were seen after exposure to ethanol, diazepam, and
copper. In addition, my study further elucidated the relationship between brain
chemistry and anxiety behaviors in fish, specifically the relationship between
brain chemistry and minnow anxiety behavior after exposure to diazepam.
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CHAPTER ONE: INTRODUCTION
A large number of American adults are using prescribed medications to
treat various anxiety disorders1. As the number continues to increase, concern
about the concentrations of these medications in the aquatic environment also
mounts as most major wastewater treatment plants do not effectively remove
these compounds, which have been detected in many effluents2,3. Previous
analytical methods have detected these drugs in the nanogram per liter to
microgram per liter range in various surface water environments4-6. In addition to
anti-anxiety medications and other pharmaceuticals, metals introduced by
anthropogenic activities are also eliciting concern about the problems increased
levels may cause in the environment. Copper is a metal both naturally found in
the earth’s crust and introduced anthropogenically via agricultural and mining
practices7. Even present at trace concentrations, these compounds have been
shown to alter organism behavior8. These changes in behavior may be linked to
changes in the brain at sites where these compounds bind to serotonin (5-HT)
and gamma-aminobutyric acid (GABA) receptors. The binding alters
neurotransmitter concentrations in the brain, eliciting changes in organism
behavior which can then lead to population level impacts in the aquatic
environment.
My research focused on the effects of three anti-anxiety drugs (diazepam
(Fig. 1.1), buspirone (Fig. 1.2), and fluoxetine (Fig. 1.3)) and copper on the brain

chemistry and behavior of the fathead minnow (Pimephales promelas). The
light-dark behavioral bioassay, a standardized assay used to measure anxiety in
both mammals and fish, was used to quantify minnow anxiety levels. Further,
changes in brain chemistry resulting from exposure to these compounds were
quantified by extracting the brains of exposed minnows and analyzing them for
decreases in specific neurotransmitters. The testable hypotheses of my research
included:
1. After exposure to either anti-anxiety medications or copper, fathead
minnows will enter the light side of the tank more often and remain on
the light side of the tank longer relative to controls.
2. Levels of 5-HT (Fig. 1.4), 5-hydroxyindoleacetic acid (5-HIAA) (Fig.
1.5) and GABA (Fig. 1.6) in the fathead minnow brain will decrease
relative to controls after exposure to anti-anxiety medications and
copper.
This research attempts to fill several gaps in the literature concerning the
effects of anti-anxiety medications on the fish neurologic system. The goal of my
research was to build on previous research conducted in our laboratory by
examining two additional classes of compounds (i.e. anxiolytics and metals) and
their effects on fish behavior and brain chemistry. This goal was achieved
through completion of the following objectives:
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1. Determine the effects of contaminants on fathead minnow anxiety
behavior.
2. Determine the effects of these compounds on fathead minnow brain
chemistry.
3. Correlate the changes in fathead minnow anxiety behavior after
exposure to these compounds with changes in brain monoamine
concentrations.

Figure 1.1 Chemical structure of diazepam (Valium®).

Figure 1.2 Chemical structure of buspirone (Buspar®).

Figure 1.3 Chemical structure of fluoxetine (Prozac®).
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Figure 1.4 Chemical structure of serotonin (5-HT).

Figure 1.5 Chemical structure of 5-hydroxyindoleacetic acid (5-HIAA).

Figure 1.6 Chemical structure of gamma-aminobutyric acid (GABA).
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CHAPTER 2: LITERATURE REVIEW
Environmental Occurrence of Pharmaceuticals and Anxiolytics
Recently, concern has been mounting about the occurrence of
pharmaceuticals in the aquatic environment and their potential effects on the
organisms that inhabit it. Little is known about the behavior and fate of these
pharmaceuticals once they enter the aquatic environment9. As such, a
significant amount of research has been done on pharmaceuticals in the aquatic
environment. Concentrations of these drugs have been detected in surface
waters in the nanogram per liter to microgram per liter range4-6. Nevertheless,
even traces of these pharmaceuticals have been shown to alter organismal
systems and animal behavior8. In addition, because these pharmaceuticals are
being released constantly and in mixtures, the potential toxic effects are complex.
A proportion of the pharmaceuticals regularly detected in surface waters
are medications prescribed to treat anxiety. These can include anxiolytics, drugs
designed to alleviate anxiety, like diazepam (Valium®), buspirone (Buspar®), and
chlordiazepoxide (Librium®), or antidepressants, like fluoxetine (Prozac®). Unlike
the more widely used pharmaceuticals such as antidepressants and personal
care products, little research has been performed and much less is known about
the behavior and fate of anti-anxiety medications once they enter the aquatic
environment.
Human use of these anxiety medications is a major point source through
which the compounds contained in these medications enter the environment.
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This source includes both consumption and direct disposal down the toilet9.
Psychoactive pharmaceuticals, including anxiolytics, are one of the most
commonly prescribed drug classes on a global scale, and the global annual
production of these drugs is increasing to meet the demands of consumers5.
According to the Anxiety and Depression Association of America (ADAA), about
13.3 million adults in the United States are treated for anxiety disorders, and
many Americans take anxiety medications without a prescription1. These
numbers are only expected to increase with time. Increases in both production
and consumption of these drugs can lead to increased concentrations of both
active and inactive metabolites in surface waters10. When taken into the body, a
large majority of these compounds usually do not reach their intended target site
and so are excreted in the active parent form11. Those compounds that do reach
their target sites are neither completely nor efficiently metabolized by the body
before being excreted as both active and inactive forms10. These compounds
enter receiving streams, rivers, and lakes through the effluents of wastewater
treatment plants that are not equipped to remove them2,3. They may be modified
even further by microorganisms during the water treatment process or after,
sometimes being transformed back into the parent form of the compound12.
Once present in aquatic ecosystems, anxiolytics have the potential to
cause a plethora of adverse effects on the environment and the organisms that
live there. Although the concentrations of anxiolytics are usually not high enough
(due to their relatively short half-lives) to cause a major toxic effect to fish and
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other aquatic organisms, their continuous entry into the aquatic environment in
mixtures is cause for concern. Behavioral changes that disrupt ecological fitness
may occur due to the highly conserved mode of action of anxiolytics on the brain
and neurotransmitter receptors. This situation has spurred much research
concerning the toxicity of these substances to aquatic organisms.
Environmental Occurrence of Copper
Anti-anxiety medications and other pharmaceuticals are only one class of
contaminants that are becoming increasingly prevalent in surface waters.
Another class of contaminants that has the potential to disrupt the aquatic
environment is metals, specifically copper. Copper is a naturally occurring metal
in the Earth’s crust and is found in surface waters as the bioavailable cupric ion
(Cu2+) where most of it is complexed or associated with organic matter7,13.
Background concentrations of naturally occurring copper in freshwater systems
range from 0.2 μg/L to 30 μg/L, but elevated levels as high as 74 μg/L have been
widely reported14,15. Copper can also be found naturally in the air, associated
with airborne particulates as well as in soils, where the mean concentration
ranges from 5 to 70 mg/kg13. It is an essential metal required by all organisms in
low concentrations (5-20 μg/g) with levels exceeding this range considered
toxic16.
In addition to being released naturally by volcanic eruptions, decaying
vegetation, and forest fires, copper also enters the environment by anthropogenic
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means including mining, agriculture, and manufacturing activities7. In 2001, an
estimated 11,100,000 pounds of copper and 1,000,000,000 pounds of coppercontaining compounds were released into the environment, with 0.4% and 0.04%
of those totals being released directly into water, respectively13. It can only be
assumed that these numbers have increased in more recent years. Most of the
copper and copper-containing compounds released from all sources (including
overburdens from copper mines and tailings, municipal sources, and pesticide
use) in 2001 was to land (approximately 92% and 99.8% of those totals,
respectively)13. Runoff and atmospheric deposition in areas where these
processes are occurring as well as inefficient removal by wastewater treatment
plants has caused significant water contamination in certain areas17-19. For
example, estimated loading rates into surface waters from agricultural runoff
ranged from 0.307 to 8.34 mg/hour in one area13.
Once present in the aquatic environment, copper can easily bind to
sediments and organic matter, thus increasing its persistence in the environment
by becoming complexed to different environmental media. Bioconcentration can
then occur in sediment dwelling organisms or be taken up by organisms living in
the water column where toxic effects can occur, although there is little evidence
that copper can biomagnify in the food chain13,16. Nevertheless, even trace
concentrations of copper have the potential to affect higher organisms.
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Mode of Action
Pharmaceuticals and Anxiolytics
Antidepressants and anxiolytics affect a number of neurotransmitters in
the brain, including serotonin and GABA. These drugs, some of which are
classified as selective serotonin reuptake inhibitors (SSRIs), can bind to and
block reuptake transporters for these neurotransmitters (Fig. 2.1). Reuptake
transporters are those on the pre-synaptic neuron that reabsorb specific
neurotransmitters after the neural impulse has been transmitted. If blocked, the
reuptake transporters can no longer reabsorb neurotransmitters, leading to an
increase of those neurotransmitters (serotonin) in the synapses. Serotonin and
GABA receptors in the vertebrate brain are highly conserved, and both serotonin
and GABA play roles in many physiological and behavioral functions in fish20.
Thus, when present in aquatic environments, these drugs have the potential to
cause significant alterations in the behavior of aquatic organisms and in turn,
affect their survival.
Anxiolytic compounds work by targeting the brain where they interact with
neurotransmitter receptors, specifically the serotonin and GABA receptors.
Serotonin is a monoamine neurotransmitter that is known to regulate mood,
appetite, and sleep. Serotonin is found in neurons of organisms from all major
clades, including vertebrates. Like other neurotransmitters, serotonin is released
into the synaptic cleft during neuronal activity and binds to specific receptors,
where it then elicits a response by activating ion channels to open and allow
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charged ions through the plasma membrane. The flow of ions causes a change
in the transmembrane potential of the neuron, which then sends an excitatory or
inhibitory signal to the brain and other parts of the body. Serotonin may also be
released outside the synapse. In this case, it exerts a more systemic effect on
surrounding neurons21. GABA is thought to be the most important excitatory and
inhibitory amino acid neurotransmitter in both the central nervous system (CNS)
and peripheral nervous system (PNS)22and is believed to regulate fear and
anxiety. It is widely distributed throughout the brain, found in 30-40% of all
synapses23. In vertebrates, GABA binds to specific transmembrane receptors at
inhibitory synapses in the brain. The process of ion exchange resulting from the
binding of GABA is similar to that which results from the binding of serotonin.
Once bound, ion channels open, causing an influx of negatively charged chloride
ions into the cell or an efflux of positively charged potassium ions from the cell.
The flow of ions results in a change in the transmembrane potential of the
neuron, which ultimately sends an excitatory or inhibitory signal to the brain and
other parts of the body.
As mentioned above, serotonin and GABA are not the only molecules that
interact with their respective receptor systems. For example, there are several
binding sites on the transmembrane GABA receptor including those for
benzodiazepines, barbiturates, and steroids24. The mode of action of anxiolytic
compounds is to interact with the receptor, either as agonists, chemicals that
bind to a receptor and trigger a response, or as positive allosteric modulators,
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chemicals that enhance the effect of an agonist. Diazepam is a positive allosteric
modulator of GABA while buspirone is a known serotonin receptor agonist.
Diazepam enhances the effect of GABA by binding to the benzodiazepine site on
the GABAA receptor and increases the affinity of GABA for its receptor (Fig. 2.2).
Buspirone is thought to bind preferentially to the 5-HT1A receptor and reduce the
synthesis and release of serotonin by acting as a partial agonist25 (Fig. 2.3).
Antagonists may also bind to the receptor, competing with either serotonin or
GABA for binding and blocking their normal functions. Fluoxetine has been
shown to bind to 5-HT2C receptors and act as a competitive antagonist74. In fact,
some of fluoxetine’s therapeutic effects seem to be linked to this blockage of 5HT receptors74. Studies performed on rats show that blockage of the GABA
receptor and thus, of the signal, by antagonistic molecules increased anxiety-like
behavior when the rats were observed in social interaction and conflict tests.
Additionally, interaction of the GABA receptor with an agonist produced
anxiolytic-like effects in the rats26. This mechanism works the same way in
invertebrates, although GABA receptors in invertebrate organisms are thought to
have less distinct pharmacological profiles and are less sensitive to some
chemicals than are vertebrate receptors27. More is known about the specific
mechanisms of the GABA receptor in the vertebrate system than in the
invertebrate system. Additionally, more research has been performed on the
mammalian system, which presents a research gap on the GABA receptor
system in non-mammals, like fish. This is also the case with serotonin, although
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anxiolytic drugs that act on the mammalian serotonergic system are believed to
act in a similar manner on fear and anxiety behaviors in fish. Previous studies
have confirmed this by measuring increased cortisol levels, an indication of
activation of the stress axis21.

Figure 2.1 Mode of action of selective serotonin reuptake inhibitors (SSRIs).
SSRIs, like fluoxetine, can bind to and block reuptake transporters on the presynaptic neuron, thus increasing the concentration of serotonin in the synapse.
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Figure 2.2 GABA receptor and the binding of GABA. Diazepam (Valium®) may
bind to the benzodiazepine site on the GABAA receptor and increase the affinity
of GABA for the receptor.
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Figure 2.3 Mode of action of buspirone (Buspar®). Buspirone may bind to the 5HT1A receptor and reduce the synthesis and release of serotonin by acting as an
agonist.
Copper
Copper is a well-known neurotoxicant and endocrine disruptor and has
been shown to affect the serotonergic system in several ways. In fact, the
serotonergic system in fish has been shown to be sensitive to various forms of
copper-induced stress28. As such, exposure to copper can also have an effect
on certain behavioral responses, although this subject has received much less
attention29,30. Some of these behavioral responses can be explained by
interference in normal function of the olfactory system in fish29,31. The olfactory
system of fish is made up of epithelial tissues embedded with ciliated olfactory
sensory neurons (OSNs). It is these OSNs that come into contact with the
surrounding water and so are very sensitive to pollutants in the aquatic
environment32. At low concentrations, copper diminishes the responsiveness of
OSNs, leaving the fish susceptible to predation33.
For aqueous copper exposure, the primary target organ is the gill
epithelium, where copper inhibits the sodium potassium-ATPase (Na+/K+ATPase) which leads to ionoregulatory imbalances and gill injury. Long-term
exposure to copper can induce stress leading to activation of the hypothalamicpituitary-adrenal (HPA) axis and cortisol release. This stress-induced stimulation
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eventually results in catecholamine release, which leads to local increases in
serotonin circulation. In contrast, studies have shown that dietary copper
exposure may cause a failure in circulating serotonin. These opposing effects
support the importance of route of exposure. In addition, there is evidence,
although speculative, that copper affects the metabolism of serotonin, causing
cross-linking and decreases in serotonin levels34.
Although not as frequently studied as pharmaceuticals, metals have also
been shown to affect monoamine neurotransmitter levels in the brain. One study
exposed common carp to aqueous copper in the form of copper nitrate. The carp
were exposed for one week. Scientists found dose-dependent decreases in
serotonin in three different parts of the brain: the telencephalon, hypothalamus,
and brain stem28. Lead causes the opposite effect, an increase in serotonin
levels in the brains of catfish35. Similarly, when fathead minnows were exposed
to aqueous lead for four weeks, researchers observed an increase in serotonin
levels35. The lack of research that has been performed concerning the effect of
metals on brain neurotransmitter systems further supports the need for my
research as a bridge to span the gap.
The Importance of Behavior as an Endpoint in Ecological Toxicity Testing
Behavior is an important and informative endpoint in toxicity testing.
Much of the concern over an increasing pharmaceutical presence in aquatic
ecosystems is the effect of these compounds on organismal behavior, even at
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trace concentrations8. Because concentrations of pharmaceuticals in the
environment are usually lower than levels that cause significant acute and
chronic toxicity, these behavioral endpoints have become quite useful as
sensitive indicators of pharmaceutical effects on organisms3,8,36,37.
To survive, an organism must be able to find and consume food, avoid
predation, and successfully reproduce to pass on its genes to the next
generation. If any of these behaviors is altered, an organism’s chance of survival
could significantly decline. Thus, chemicals like anxiolytics and antidepressants
that alter fear and anxiety responses could potentially interfere with the behavior
of an organism and cause its fitness to decline. Exposure may lead to
anxiogenic-like, or increased anxiety-like behaviors. Organisms may be too
anxious to interact socially with other organisms. For example, schooling
behaviors may change or organisms may become reluctant to leave the safety of
their shelter to find food and reproduce, negatively affecting their ability to
survive. The opposite effect is seen in studies that explore the effects of
neurotransmitter receptor agonists. These types of compounds cause an
increased cellular signal that elicits anxiolytic effects, making organisms less
anxious over exploring new environments and the approach of other
organisms26,38. Organisms may ignore their basic survival instincts and disregard
an approaching predator. Copper can affect basic behavioral functions like
olfaction, or work by interfering with metabolic processes such as the breakdown
of serotonin in the brain30,34,39. Because of this effect on serotonin, copper, like
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anxiolytic drugs, has been hypothesized to affect anxiety behavior. All of the
above situations thus have the potential to lead to effects on the population and
even the ecosystem40.
Various studies have investigated the effect of anxiolytics and copper on
organism behavior in order to determine the sub-lethality of these contaminants.
Feeding behavior is a common behavioral endpoint in toxicity testing. After
exposure to sub-lethal concentrations of SSRI fluoxetine, hybrid striped bass
exhibited a decrease in ability to capture prey. This concentration- and timedependent decrease was correlated with depressed serotonin levels in the
brain37. Similarly, hybrid striped bass exposed to venlafaxine exhibited an
increased time to capture prey while simultaneously exhibiting decreased brain
serotonin levels36. Similar research involved juvenile perch that were exposed to
sertraline, an SSRI. The perch exhibited decreased foraging behaviors with
increasing concentrations of sertraline20.
Anxiety behavior is another behavioral endpoint that is commonly tested.
Researchers exposed zebrafish to fluoxetine, buspirone, and diazepam and
observed their behavior in the light-dark box scototaxis test. Chronic treatments
with fluoxetine increased the time zebrafish spent in the white compartment while
diazepam and buspirone produced similar effects41. The ability of fathead
minnows to avoid predators was investigated after embryos were exposed to
several common antidepressants at environmentally relevant concentrations,
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either singularly or in mixtures. The C-start response, or escape reflex, of
minnows was adversely affected by exposure to fluoxetine, venlafaxine, and
bupropion singularly. Mixtures of these antidepressants also slowed predator
avoidance behaviors in the minnows42.
Reproductive behavior is yet another endpoint used in toxicity testing
following exposure to pharmaceuticals. Concentrations of fluoxetine as low as 1
μg/L significantly affected male mating behaviors, specifically nest building and
nest defending. At higher concentrations, males exhibited aggression, isolation,
and repetitive behaviors43. Antidepressants have also been found to disrupt the
reproductive system of molluscs, specifically spawning and larval release.
Adverse reproductive effects following antidepressant exposure have also been
discovered in amphipods and daphnids44.
Coho salmon that were exposed to increasing, but sub-lethal
concentrations of copper had an impaired sense of smell to natural odorants
within 10 minutes of exposure. Researchers concluded that copper is broadly
toxic to the salmon olfactory system29. A second study on copper focused on
shoaling behavior in killifish. Shoaling occurs when fish congregate in groups for
social reasons. Exposure to acute copper resulted in decreases in time to first
shoaling and total time spent shoaling30. The above evidence confirms that
important behavioral and physiological processes can be affected by chemicals
in the environment and cause a decline in an organism’s ability to survive,
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stressing the importance of behavioral endpoints in ecological toxicity testing
following exposure to environmental contaminants.
Quantifying Anxiety Behavior in Fish
Anxiety behavior is a very useful and informative endpoint that is
becoming increasingly popular in toxicity testing. Because it is considered a
sublethal endpoint, the effects of certain toxicants on this behavior can easily be
observed and quantified. As such, several different bioassays have been
developed to observe and quantify anxiety behavior in both mammals and fish.
Zebrafish (Danio rerio) are becoming increasingly promising as a model
organism for stress and anxiety research. The potential for the use of this
species has emerged quite recently. Zebrafish are useful because they possess
all of the standard vertebrate neurotransmitters and serve as non-mammalian
organisms that are physiologically homologous to humans. In addition, much is
known about their genome and their neuroendocrine system responds well to
stress in the form of physiological responses making them a useful species for
behavioral bioassays45,46. The two most widely used behavioral assays that
employ zebrafish as the model organism are the novel tank diving test and the
light-dark scototaxis test. The novel tank diving test involves a tank divided into
sections (top, bottom, etc.) and explores the zebrafish’s instinctual response to
seek shelter in unfamiliar environments by diving to the bottom of the tank and
remaining there until the fish feels safe enough to explore. Researchers assess
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anxiety by quantifying latency to enter the upper half and time spent in each
compartment as well as specific behaviors, including erratic movements and
freezing. The test relies on an exposure to novelty for quantifying anxiety
responses in zebrafish, with longer latencies to enter the upper compartment,
reduced time spent in the top compartment, increased erratic movements, and
freezing as measures of increased anxiety. The light-dark scototaxis test, also
known as the light-dark preference test, is similar in that it also relies on
exposure to novelty. However, the tank is divided into equal light and dark or
white and black compartments. It has been suggested in a previous study that
zebrafish prefer a darker environment47 and it is this preference on which the test
is based. Entries to the light compartment and time spent in the light
compartment per entry are quantified with increased entries and more time spent
in the light compartment being indicative of decreased anxiety behavior. A third,
less common behavioral assay is the open field test which consists of a large
open space divided into inner and outer zones. The assay relies on the zebrafish
to display behaviors associated with thigmotaxis, or avoiding the center of a
novel area and moving in close proximity to the boundaries of said novel area48.
Variations of these tests have also proven useful for investigating anxiety
behavior in zebrafish as well as other organisms.
Zebrafish are usually exposed to certain anxiolytic or anxiogenic drugs
before being subjected to one or both of these tests, although researchers have
investigated the effects of restraint stress on zebrafish behavior instead of
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chemical exposure48. These drugs can serve as positive controls for these
behavioral bioassays, allowing researchers to investigate the effects of other
compounds not usually used with these assays. Researchers administered a
chronic treatment of fluoxetine (100 µg/L) to zebrafish over a period of two weeks
and observed them in the novel tank diving test. The exposed fish displayed
anxiolytic behaviors in the form of lower latency to enter the top compartment,
more time spent in the top compartment, and a decreased number of erratic
movements as compared to controls45. A second study investigated the effects
of fluoxetine, buspirone, diazepam, and ethanol on zebrafish anxiety behavior
using the light-dark scototaxis test. Fish were injected with 5 or 10 mg/kg
fluoxetine, 25 or 50 mg/kg buspirone, or 0.02 or 0.2 mg/kg diazepam. Fish
injected with 10 mg/kg fluoxetine spent more time in the light side of the tank
while those injected with buspirone spent more time in the light side at both
doses. Diazepam-injected fish also showed an anxiolytic effect. Additionally,
fish that were exposed to 0.25% ethanol spent more time on the light side of the
tank41. Other studies show similar results of anxiolytic compounds decreasing
anxiety behavior in fish49-51. The effects of nicotine, cocaine, and caffeine have
also been investigated using these behavioral tests41,52,53. Because of the
validity and plasticity of these behavioral assays, the results may be applied to
other areas including genetics and medicine, setting the scene for further
advances in these fields54,55.
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Quantifying Neurotransmitters in Biological Samples
Several previous studies have been able to quantify the concentrations of
neurotransmitters in biological samples from mammals, including humans, and
from fish. Methods using various forms of chromatography: gas chromatography
(GC), high performance liquid chromatography (HPLC), and liquid
chromatography/tandem mass spectrometry (LC-MS/MS), have reported
accurate and reliable results for the analysis of neurotransmitters, including
serotonin and GABA. One study quantified levels of three monoamine
neurotransmitters (dopamine, norepinephrine, and serotonin) as well as
melatonin and its metabolite, 7D-melatonin, in the brains of sea lampreys
(Petromyzon marinus) using an LC-MS/MS method with a reversed-phase
column. Pre-treatment of samples included solid-phase extraction (SPE) to
purify and extract the target compounds from samples. Researchers were able
to quantify all five compounds with extreme accuracy and limits of detection of
0.14, 0.09, 0.07 ng/mL for norepinephrine, dopamine, and serotonin,
respectively. The same study also investigated the stability of these compounds
at 4°C in the dark. Serotonin and dopamine were stable for up to three days and
one day, respectively, although norepinephrine was not found to be stable under
these conditions. In addition, the accuracy of three different types of SPE
cartridges was tested. Recoveries were highest for samples that were prepared
using Bond-Elut C18 cartridges56. Another study utilized HPLC with fluorescence
detection to analyze the concentrations of 5-HT and 5-HIAA in sea lamprey
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plasma samples. SPE was performed with Oasis HLB cartridges. Limits of
detection ranged from 0.04 to 0.13 ng/mL57. Using an HPLC method with
electrochemical detection, GABA and dopamine levels were quantified in the
hypothalamus of largemouth bass (M. salmoides) in the nmol/g range58. In
addition to the latter, there have been other studies performed using both whole
and partial fish brain samples in several different species, including the fathead
minnow, goldfish, trout, and carp28,59-61. Finally, one study quantified free GABA
in the cerebrospinal fluid of humans in the nmol/L range using an isocratic HPLC
method with electrochemical detection62.
With the recent advances in analytical analysis of biological samples,
neurotransmitter detection methods are becoming more efficient and accurate.
Researchers developed a method using LC-MS/MS to quantify GABA and
glutamate in rat brain microdialysis samples with a limit of quantitation of 1 and
10 nM, respectively. The use of a hydrophilic interaction liquid chromatography
(HILIC) column allowed researchers to separate the polar analytes from the
sample matrix, and thus, the pre-treatment of samples was not required, making
this method more efficient than previously reported methods. In addition, when
compared with previous methods, this method has a higher sensitivity, is more
selective, and is more rapid with a run time of three minutes23. A second study
involving rat microdialysis samples was able to detect GABA and glutamate at
even lower concentrations (0.03 and 0.8 pmol, respectively). However, in
contrast to the previous study, researchers utilized an HPLC method which
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allowed for detection of very low amounts of these neurotransmitters22. This
evidence, along with many other studies, demonstrates the ability of researchers
to efficiently and accurately quantify neurotransmitter levels in many types of
biological samples.
Although behavioral research after chemical exposure is plentiful, only a
few studies have actually correlated changes in behavior following chemical
treatment to changes in brain chemistry in fish21. Previous research in our lab
found a negative correlation between time to capture prey and brain serotonin
activity in hybrid striped bass (M. saxatilis x M. chrysops) after exposure to
fluoxetine37. With the completion of this research, I hope to also correlate
changes in fish behavior, specifically anxiety behavior, and decreases in
neurotransmitter activity.
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CHAPTER 3: MATERIALS AND METHODS
Test Chemicals
Methanol, acetonitrile, glacial acetic acid, and triethylamine were all HPLC
grade and purchased from Fisher Scientific (Fair Lawn, NJ, USA). The nitric acid
and hydrochloric acid used to acidify collected water samples were Trace Metal
Grade and also purchased from Fisher Scientific (Fair Lawn, NJ, USA). The
fluoxetine hydrochloride used in all experiments was generously donated by
Fermion in Finland. Buspirone hydrochloride and copper (II) sulfate pentahydrate
were purchased from Alfa Aesar (Ward Hill, MA, USA). Absolute ethanol was
purchased from Aldrich (Ward Hill, MA, USA). The diazepam was purchased
from Qualitest Pharmaceuticals (Huntsville, AL, USA) through Godley-Snell
Research Center (Clemson, SC, USA). Water used for all analytical procedures
was passed through a Milli-Q-Super-Q Filtration system (Millipore®, Billerica, MA,
USA) so that it was ultra-purified and had a measured resistance of 18 mΩ∙cm.
Exposures were conducted in moderately hard reconstituted water that was
prepared according to the US EPA recipe: 190 L Millipore® Milli-Q water, 11.4 g
CaSO4, 11.4 g MgSO4, 0.76 g KCl, and 18.24 g NaHCO363. All salts for
moderately hard water were purchased from Fisher Scientific (Fair Lawn, NJ,
USA). Tricaine-S (MS-222) used for euthanizing minnows was purchased from
Western Chemical (Ferndale, WA, USA.
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Fish
Fathead minnows (Pimephales promelas) were either purchased from I.F.
Anderson Minnow Farm (Lonoke, AR, USA) or caught in traps that were
deployed in ponds at the Cherry Farm Aquatic Research Lab at Clemson
University (Clemson, SC, USA). The minnows were held in 100 L holding
troughs that were maintained as flow through systems, supplied with fresh water
from Lake Hartwell (Clemson, SC, USA) (pH=6.28 ± 0.17, Hardness=24 mg/L as
CaCO3, Alkalinity=10 mg/L as CaCO3). The water was filtered and sterilized
before reaching the holding troughs. Water temperature was maintained within a
range of 20-27°C. The water contained within the holding troughs was constantly
aerated through airstones. During holding, minnows were fed a commercial diet
of Tetramin® Tropical Flakes that were purchased from Dr.’s Foster & Smith, Inc.
(Rhinelander, WI, USA). Minnows were transported to the Clemson University
Institute of Environmental Toxicology (Pendleton, SC, USA) for all exposures and
allowed to acclimate for at least 2 days in a 33 L (20” x 10” x 12 ½“) holding
aquarium. The holding aquarium was maintained as a recirculating system with
a Tetra® Whisper® filter containing Ultra-activated® carbon (Blacksburg, VA,
USA) and contained moderately hard reconstituted water according to the US
EPA’s recipe above. The holding aquarium was constantly aerated using an
airstone, and minnows were fed the same commercial diet of Tetramin® Tropical
Flakes purchased from Dr.’s Foster & Smith, Inc. (Rhinelander, WI, USA).
Minnows chosen for exposures were approximately 5-6 cm in size.
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Experimental Design

All exposures were conducted in an animal testing room at the Clemson
University Institute of Environmental Toxicology (Pendleton, SC, USA).
Exposure aquaria (2 L, 24 cm x 6.4 cm x 16.5 cm) were half covered with black
plastic sheeting (Sunbelt Plastics, Monroe, LA, USA) to simulate a “light”
environment and a “dark” environment (Fig. 3.1). A clear plastic cover was also
half covered with the same black plastic sheeting and placed on top of each
aquarium to prevent minnows from jumping out and also significant evaporation
of the water. Each exposure aquarium was aerated with two airstones, one on
the “light” side and one on the “dark” side to prevent minnows from preferentially
choosing the side of the tank with the airstone. Twelve exposure aquaria (n=3
per treatment) were placed on a metal rack with three shelves so that there were
four aquaria per shelf (Fig. 3.2). A white bed sheet was hung behind the metal
rack to make filming and visual observation of each tank easier. Volumes of 1.8
and 0.9 L were measured and marked on each exposure aquarium to indicate
the fill lines for exposure volume and half renewal volume on half-renewal days,
respectively. Concentrations included a low, medium, and high treatment along
with a control for each chemical and were randomly assigned to each exposure
aquarium so that there were three replicate exposure aquaria for each of the four
concentrations. After the acclimation period, minnows were transferred from the
33 L holding aquarium to the exposure aquaria so that there was one minnow per
aquarium. Each exposure aquarium was spiked with the appropriate amount of
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drug and subsequently re-spiked with half of the original amount on half renewal
days according to the half-life of each drug. Stock solutions of each drug were
remade for each exposure. Water samples were taken two hours after the initial
spike on Day 0 and after each re-spike on renewal days to allow for equilibration.
Water samples were acidified with the appropriate acid and stored at 4°C until
further analysis. Acute exposures lasted for 24 hours while long-term exposures
lasted for nine days. Time-points were taken at 30 minutes, 3 hours, 12 hours,
and 24 hours after exposure for acute exposures and 30 minutes (Day 0), Day 3,
Day 6, and Day 9 for long-term exposures so that there were a total of four timepoints for each exposure. Time-points during long-term exposures were taken at
the same time each day. For each time-point, minnow behavior was recorded
with a video camera from outside the animal testing room so as not to disturb the
minnows. The number of entries of each minnow to the light side and the
duration of each entry was recorded. An “entry” was defined as any time when at
least half of the minnow body was on the light side of the aquarium. During
exposure, minnows were fed the same commercial diet of Tetramin® Tropical
Flakes every day purchased from Dr.’s Foster & Smith, Inc. (Rhinelander, WI,
USA). In addition, water quality measurements (temperature in °C, dissolved
oxygen in mg/L, alkalinity as CaCO3, hardness as CaCO3, and pH) were
recorded every day with a YSI™ 556MPS Meter and a ProODO™ Meter (YSI
Incorporated®, Yellow Springs, OH, USA). During exposures, the testing room
was not entered unless absolutely necessary, to avoid influencing the behavior of
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the minnows. After the completion of each exposure, minnows were euthanized
in a solution of MS-222 (Western Chemical, Ferndale, WA, USA), and their
brains were extracted and stored in a -80°C freezer until further analysis. Due to
limited sample size (n=3 per treatment), brains were only extracted after 24 hours
for acute exposures and after nine days for long-term exposures.

Figure 3.1 A single exposure aquarium with the left half covered with black
plastic sheeting.
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Figure 3.2 Exposure aquaria setup.
Diazepam, Buspirone, and Fluoxetine Half-Life Studies
The stabilities of diazepam, buspirone, and fluoxetine were investigated to
determine if subsequent additions of the chemical would be necessary to
maintain constant concentrations throughout the duration of the experiments.
Prior to the initiation of exposures, a two-day stability experiment was performed.
The same experimental setup as described above was used. A single minnow
was added to each exposure aquaria to simulate the same conditions as during
the actual experiment. Water samples were collected from each aquarium daily
and measured to determine drug concentrations.
Ethanol Exposures
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Absolute ethanol (Aldrich, Ward Hill, MA, USA) was used as a positive
control to ensure the validity of the light-dark behavioral bioassay. In scientific
experiments, the positive control is a treatment with a known response. Nominal
concentrations chosen included 0.25%, 0.5%, and 1.0% (v.v.) along with a
negative control. Half water renewals and re-spikes occurred every three days
for long-term exposures. Renewals and re-spikes were not performed for acute
exposures.
Diazepam, Buspirone, and Fluoxetine Exposures
Spiking solutions of diazepam were prepared by dissolving a 10 mg pill in
10 mL of methanol and placing on a stir plate to equilibrate for 24 hours. Spiking
solutions of buspirone and fluoxetine were prepared by dissolving buspirone
hydrochloride and fluoxetine hydrochloride in methanol. Concentrations of
spiking solutions were selected so that there was no more than 0.1mg/L
methanol in the exposure tanks. This value is the ASTM recommendation for
methanol as the carrier solvent73. The control tanks were spiked with the highest
volume of methanol that was calculated from desired exposure concentrations to
ensure there was no toxicity due to the carrier solvent. Nominal concentrations
chosen included 35, 75, and 150 μg/L along with the control. These
concentrations were chosen because previous research in our lab discovered
decreases in bass serotonin levels after exposure to similar concentrations of
fluoxetine36,37. New spiking solutions were prepared for each exposure. The
half-lives of diazepam, buspirone, and fluoxetine were determined to be about
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one day. To maintain constant concentrations of these drugs throughout the
duration of the experiment, re-spikes occurred every day for long-term exposures
with appropriate volumes of diazepam, buspirone, and fluoxetine spiking
solutions to reach nominal concentrations. To prevent the buildup of nitrogenous
waste products, 50% of the aquaria water was renewed every day prior to respiking. Aquaria were then re-spiked with the appropriate volume of spiking
solution, taking into account the half-life of each drug and the volume of water
removed from the tank. Renewals and re-spikes were not performed for acute
exposures. Water samples were taken two hours after the initial spike on Day 0
and after each respike on Days 3, 6, and 9 for verification of drug concentrations.
Water samples were acidified with three drops of 2 M hydrochloric acid and
stored at 4°C until further analysis.
Copper Exposures
Spiking solutions of copper were prepared by dissolving copper (II) sulfate
pentahydrate in Milli-Q water. Nominal concentrations chosen included 20, 40,
and 80 μg/L. These concentrations were modeled after previous research that
observed decreases in brain serotonin levels in three different parts of carp
brains after exposure to copper28. Because the carrier solvent for copper was
Milli-Q water, nothing was added to control tanks. New spiking solutions were
prepared for each exposure. Previous research determined that copper was
relatively stable in this system and had a half-life of about three days (data not
shown). To maintain constant concentrations of copper throughout the duration
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of the experiment, re-spikes occurred every three days for long-term exposures
with appropriate volumes of copper spiking solutions to reach nominal
concentrations. To prevent the buildup of nitrogenous waste products, 50% of
the aquaria water was renewed every three days prior to re-spiking. Aquaria
were then re-spiked with the appropriate volume of copper spiking solutions,
taking into account the stability of copper and the volume of water removed from
the tank. Renewals and re-spikes were not performed for acute exposures.
Water samples were taken two hours after the initial spike on Day 0 and after
each respike on Days 3, 6, and 9 for verification of copper concentrations. Water
samples were acidified with nitric acid and stored at 4°C until further analysis.
Verification of Diazepam, Buspirone, and Fluoxetine Concentrations
To confirm exposure concentrations, water samples were taken every day
prior to re-spiking. Samples were collected in the appropriate volumetric flask
and acidified with three drops of 2 M hydrochloric acid. Samples were extracted
immediately on 3 mL HyperSep C-18 SPE cartridges with a bed weight of 500
mg (Thermo Fisher Scientific, Pittsburgh, PA, USA). Prior to extraction,
cartridges were conditioned with 3 mL of acetone, 3 mL of methanol, and 6 mL of
Milli-Q water. Samples were then loaded onto the cartridges. After the entire
sample had passed through the cartridge, the cartridges were dried under
vacuum for at least 30 minutes. Cartridges were eluted immediately with a
solution of methanol and 1% acetic acid. Elute was collected and stored in
sample vials at 4°C until HPLC analysis.
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The HPLC system consisted of a Waters 1525 Breeze HPLC Pump, a
Waters 717 Plus auto sampler, a Waters 2475 multi-wavelength fluorescence
detector, and Waters 2487 multi-wavelength absorbance detector (Waters,
Milford, MA, USA). A Varian Polaris 5 C-18A reverse phase analytical column
(250 mm long, 4.6 mm I.D.) (Varian Inc., Lake Forest, CA, USA) was used to
achieve chromatographic separation. The mobile phase for diazepam consisted
of 60:40 HPLC grade acetonitrile: Milli-Q water adjusted to a pH of ~2 with glacial
acetic acid and 0.1% triethylamine. The mobile phase for buspirone consisted of
35:65 HPLC grade acetonitrile: Milli-Q water adjusted to a pH of ~3 with glacial
acetic acid and 0.1% triethylamine. The mobile phase for fluoxetine consisted of
40:60 HPLC grade acetonitrile: Milli-Q water adjusted to a pH of ~3 with glacial
acetic acid and 0.4% triethylamine. All mobile phase solutions were filtered
through a 0.45 µm nylon filter and degassed for at least 30 minutes using a
sonication bath. The flow rate was 1mL/min and a 40 μL injection volume was
used. For diazepam, the absorbance detector was set to 238 nm, and the
retention time was approximately six minutes. The absorbance detector was set
to 240 nm for buspirone while the retention time was approximately six minutes.
For fluoxetine, the fluorescence detector was set at an excitation wavelength of
270 nm and an emission wavelength of 300 nm. The retention time for fluoxetine
was approximately 11 minutes.
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Verification of Copper Concentrations
To confirm exposure concentrations, water samples were taken every
three days prior to re-spiking. Samples were collected in 15mL Falcon tubes
(VWR International, West Chester, PA, USA), acidified with nitric acid, and stored
at 4°C until ICP-MS analysis.
Preparation of Brain Tissue
When ready for analysis, brains were collected from storage in -80°C.
Individual brains were weighed and transferred to new 1.5 mL centrifuge tubes
(Eppendorf, Westbury, NY, USA). Brains were homogenized using a 400 W, 20
kHz Digital-Model 450 Sonifier (Branson, Danbury, CT, USA) in 30 µL of Milli-Q
at 10% amplitude for five seconds. Three volumes (90 µL) of cold acetonitrile
were added to each tube. Samples were then incubated at -80°C for ~45
minutes and centrifuged for five minutes at 4°C and 14,000 rpm. The
supernatant was collected and incubated for another 45 minutes. Samples were
centrifuged at the same settings and the supernatant was collected. Additional
protein precipitation steps (incubation for ~45 minutes and centrifugation for five
minutes) were taken if supernatant remained cloudy after the second
centrifugation. Once the brain tissue samples were separated from the
precipitated proteins, the samples were stored at -80°C until LC-MS/MS analysis.
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Protein Concentration Analysis
Brain protein concentrations were measured using a BCA™ Protein Assay
Kit (Pierce, Rockford, IL, USA). The diluent for standard curve was 10%
acetonitrile. A 10 μL aliquot of each brain sample was diluted 1:10 in Milli-Q
water before analysis. A 25 µL aliquot of this solution was then loaded into each
well. A volume of 200 µL of working reagent was also added to each well.
Samples were run in triplicate. Once the plate had been loaded with all
standards and samples, it was incubated at 37°C for 30 minutes. The plate was
then cooled to room temperature and measured at an absorbance of 526 nm on
a SpectraMax® 190 microplate reader (Molecular Devices, Sunnyvale, CA,
USA). Brain neurotransmitter concentrations were normalized to the observed
protein concentrations.
LC-MS/MS Analysis for Neurotransmitters
Brain samples were analyzed for 5-HT, 5-HIAA, and GABA using a
Shimadzu LC-MS/MS 8030 (Kyoto, Japan) equipped with a communications bus
module (CBM-20A), a degasser (DGU-20A5), a liquid chromatograph (LC-20AT),
and an auto sampler (SIL-20HT). The mobile phase consisted of 100% methanol
and 0.03% formic acid in LC-MS/MS grade water and was run on a gradient
(Table 3.1). From 2 to 8 minutes, the flow increased from 5 to 95% methanol,
from 8 to 11 minutes, the flow remained stable at 95% methanol, and at 11.01
minutes, the flow decreased to 5% methanol to allow for the instrument to
recalibrate before the next sample was injected. The injection volume was set at
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2 µL. The run time was 11 minutes. Retention times for the analyzed
monoamines were 2.1, 5.5, and 9.5 minutes for 5-HIAA, 5-HT, and GABA,
respectively.
Table 3.1 LC-MS/MS mobile phase gradient.
Time (min)

% Methanol

2

5

8

95

11

95

11.01

5

Data Analysis
Behavioral data were analyzed using JMP Pro 10 Statistical Discovery
software (SAS, Cary, NC, USA). A model was developed that included terms for
the fixed effects of drug concentration, time-point, and time-point by
concentration interaction; and random effects of exposure number, concentration
by exposure number interaction, and tank nested within exposure number and
concentration combinations. ANOVA was used to test the significance of the
model terms. If model terms were found to be significant, then Fisher's Protected
Least Significant Difference test was used to compare the least squares means
and determine the nature of the effects.
Brain neurotransmitter data were also analyzed using JMP Pro 10
Statistical Discovery software (SAS, Cary, NC, USA). ANOVA was used to test
the significance of the linear relationship between concentration and
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neurotransmitter level. Then Dunnett’s test was used to compare the means of
the control groups to the means of the treatment groups. In addition, behavioral
and brain neurotransmitter data were log transformed and ANOVA was used to
test the significance of the behavioral data as a function of the brain
neurotransmitter data.
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CHAPTER 4: RESULTS AND DISCUSSION
Water Quality Measurements
Water quality measurements were averaged (mean ± standard deviation)
for all exposures. Measurements included pH, temperature, dissolved oxygen,
alkalinity, and hardness. The pH, temperature, dissolved oxygen, alkalinity, and
hardness were 8.04 ± 0.31, 23.15°C ± 0.84, 9.16 mg/L ± 0.48, 52.24 mg/L ± 3.66
as CaCO3, and 83.69 mg/L ± 5.24 as CaCO3, respectively.
Diazepam, Buspirone, and Fluoxetine Concentrations
Diazepam
Average diazepam concentrations (mean ± standard deviation) for
behavioral exposures were 30.49 ± 8.69, 68.87 ± 14.24, and 136.09 ± 33.22
µg/L. Nominal diazepam concentrations were set at 35, 75, and 150 µg/L.
Concentrations remained stable over the course of the exposures. Diazepam
concentrations by exposure day are shown in Figure 4.1.
Buspirone
Average buspirone concentrations (mean ± standard deviation) for
behavioral exposures were 24.90 ± 8.25, 53.43 ± 16.71, and 116.04 ± 39.53
μg/L. Nominal buspirone concentrations were set at 35, 75, and 150 μg/L.
Concentrations remained stable over the course of the exposures. Buspirone
concentrations by exposure day are shown in Figure 4.2.
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Fluoxetine
Average fluoxetine concentrations (mean ± standard deviation) for
behavioral exposures were 20.93 ± 6.49, 53.72 ± 12.46, and 117.22 ± 36.64
μg/L. Nominal fluoxetine concentrations were set at 35, 75, and 150 μg/L.
Concentrations decreased after Day 0, but then remained stable over the
remaining days of the exposures. Fluoxetine concentrations by exposure day are
shown in Figure 4.3.
Copper Concentrations
Average copper concentrations (mean ± standard deviation) for behavioral
exposures were 31.86 ± 5.17, 42.95 ± 6.28, and 79.02 ± 11.34 μg/L. Nominal
copper concentrations were set at 20, 40, and 80 μg/L. Concentrations remained
stable over the course of the exposures. Copper concentrations by exposure
day are shown in Figure 4.4.
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Figure 4.1 Diazepam concentrations throughout the course of the behavioral
exposures by exposure day. Nominal concentrations were 35, 75, and 150 µg/L.
Error bars represent ±1 standard deviation.
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Figure 4.2 Buspirone concentrations throughout the course of the behavioral
exposures by exposure day. Nominal concentrations were 35, 75, and 150 µg/L.
Error bars represent ±1 standard deviation.
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Figure 4.3 Fluoxetine concentrations throughout the course of the behavioral
exposures by exposure day. Nominal concentrations were 35, 75, and 150 µg/L.
Error bars represent ±1 standard deviation.
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Figure 4.4 Copper concentrations throughout the course of the behavioral
exposures by exposure day. Nominal concentrations were 20, 40, and 80 µg/L.
Error bars represent ±1 standard deviation.
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Qualitative Behavioral Observations
In addition to the two quantitative endpoints discussed below, qualitative
observations concerning minnow behavior were also made. During exposures,
specifically long-term exposures, minnows seemed less anxious during water
changes and re-spikes. Minnows did not flee to the dark side when these events
were occurring indicating an anxiolytic state. In addition, “freezing” behavior was
observed. Freezing is defined as the complete cessation of movement where
only the eyes and gill opercula may move. This behavior has been associated
with fear and anxiety-inducing stimuli64. Of the fish that displayed freezing
behavior, most were either control fish or those exposed to the lowest drug
concentration which supports the hypothesis that exposure to anxiolytic drugs
reduces anxiety-like behaviors in fish.
Ethanol: Behavioral and Brain Chemistry
After acute exposure to ethanol (positive control, see Ethanol Exposures,
pg. 30) there were no significant differences among concentrations in number of
entries into the light side. There was a significant difference among time-points,
however. Number of entries at the 0.5 hr time-point was significantly larger than
the number of entries at the 24 hr time-point (Fig. 4.5). While the variability
among replicates reduced statistical power, the dose-related increase in entries
into the light side of the tank at the 0.5 hr time-point after treatment is obvious.
The same trend existed for time spent in the light side of the tank at 0.5 hr after
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treatment (Fig. 4.6). Both of these trends disappear at longer exposure times.
These results suggest that ethanol produces an anxiolytic effect in minnows at
the onset of exposure, but as time goes on, it has a depressive effect which is
not surprising since ethanol is a known sedative. Moreover, as ethanol was the
positive control for this assay, I expected an anxiolytic effect.
After acute ethanol exposure, there were significant decreases in all three
neurotransmitters measured (Fig. 4.7). A strong negative correlation was found
between ethanol concentration and serotonin and 5-HIAA levels (R2=0.8602 and
0.7054, respectively) although the linear relationships between these
neurotransmitters and ethanol concentration were not significant (Table 4.1).
GABA levels decreased in minnows exposed to lower concentrations of ethanol,
but increased in minnows exposed to the highest concentration. This
relationship was found to be significant with a p-value of 0.0471. As for 5-HIAA,
minnows had significantly decreased levels after exposure to 1% ethanol.
Serotonin levels were highest, followed by 5-HIAA and GABA.
Minnow GABA and 5-HIAA levels were found to be significantly lower than
the control after long-term exposure to 0.25 and 0.5% ethanol (Fig. 4.8). Levels
of these neurotransmitters increased slightly in minnows after exposure to 1%
ethanol. No significant relationships were found between ethanol concentration
and serotonin levels, although a decreasing trend in these levels was observed.
Serotonin was found in the highest quantity in minnow brains followed by GABA
and 5-HIAA.
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Figure 4.5 Number of entries by minnows to the light side of the tank after acute
(1 d) exposure to ethanol. Control = 0%, Low = 0.25%, Medium = 0.5%, High =
1%. Error bars represent ±1 standard error. Capital letters represent statistical
differences among time-points. Lowercase letters across the top represent
statistical differences among concentrations.
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Figure 4.6 Time spent in light by minnows after acute (1 d) exposure to ethanol.
Control = 0%, Low = 0.25%, Medium = 0.5%, High = 1%. Error bars represent ±1
standard error. Capital letters represent statistical differences among timepoints. Lowercase letters across the top represent statistical differences among
concentrations.
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Figure 4.7 Minnow neurotransmitter concentrations after acute (1 d) exposure to
0.25, 0.5, and 1% ethanol. Brains were extracted one day after exposure. Error
bars represent ±1 standard error. Asterisks represent significant difference from
the control. Equations and correlation coefficients are shown above and below
their respective lines. p GABA=0.0471, p 5-HT=0.1385, p 5-HIAA=0.4046.
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Figure 4.8 Minnow neurotransmitter concentrations after long-term (9 d)
exposure to 0.25, 0.5, and 1% ethanol. Brains were extracted one day after
exposure. Error bars represent ±1 standard error. Asterisks represent significant
difference from the control.
Table 4.1 P-values and R2 values for neurotransmitter regression lines after
acute exposure to ethanol.

Neurotransmitter

P-value

R2 value

GABA

0.0471

0.049

5-HT

0.1385

0.8602

5-HIAA

0.4046

0.7054

There were no significant differences in either number of entries or time
spent on the light side of the tank in the long-term ethanol exposures (Fig. 4.6).
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Mathur and Guo exposed zebrafish to 0 and 1% ethanol for 8 days (20 min/day)
and observed their behavior during a withdrawal period. In contrast to our
results, zebrafish exposed to 1% ethanol spent more time in the light
compartment relative to control minnows. No effect was found on number of
entries to the light compartment51. Based on these results, ethanol does not
have a long-term effect on fathead minnow locomotion or anxiety behavior.
A previous study observed a concentration effect on both anxiety and
locomotion after exposure to ethanol41. In that study, zebrafish exposed to 0.5%
ethanol had more midline crossings and spent more time in the light
compartment relative to control minnows. A second study found that zebrafish
exposed to 0.5 and 1% ethanol spent more time in the light compartment
compared to control fish. In addition, zebrafish exposed to 1.5% ethanol made
more entries to the light compartment, but had decreased time spent in the light
compartment51, which was similar to our results. However, these studies only
looked at zebrafish behavior for 15 and 5 minutes each, respectively. In contrast,
our study observed minnow behavior for 15 minutes at 4 different time-points
after exposure. Further, the second study observed zebrafish during a
withdrawal period and not in exposure water, as our study did. We found that
minnows were more active and spent more time on the light side early in the
exposure and had decreased activity and time spent in the light compartment at
later time-points, suggesting an anxiogenic (increase in anxiety) effect of ethanol
as the experiment proceeded. Extended exposure to ethanol may have caused
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depression in the minnows so that as time passed, they became less active and
did not explore the exposure tank. The fact that previous studies only observed
fish behavior for a short period of time could explain some of the differences
between results.
In addition, a major difference between my study and previous studies is
that the latter used zebrafish as a model organism. The light-dark behavioral
bioassay was developed using zebrafish46. However, I used fathead minnows
because they are a ubiquitous species and thus, more relevant in this context.
Species differences could be a driving factor causing opposite results in our
study as compared to others. Egan et al. observed differences in anxiety
behaviors between different strains of zebrafish, suggesting a genetic component
to anxiety behavior45. Thus, this type of behavior may not translate the same
way in fathead minnows. In the future, this experiment could be performed using
zebrafish to characterize any possible species differences.
As depicted in Figure 4.7, there was a trend of dose-dependent decrease
in brain serotonin levels in response to increasing ethanol concentration.
However, due to high replicate variability this relationship was not found to be
statistically significant. Ethanol is a known positive allosteric modulator of the
serotonin receptor and has been shown to decrease serotonin levels and affect
serotonin metabolism68,69. Hence, I expected an effect of ethanol on serotonin
levels in the minnow brain. GABA levels also decreased significantly at 0.5%
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ethanol. However, minnows exposed to 1% ethanol had increased GABA levels
compared to those exposed to 0.5% ethanol. This finding suggests that there is
a threshold of ethanol exposure below which GABA levels decrease while above
which, there was no observable effect on brain GABA concentrations. Above this
threshold, GABA receptors could become saturated, leading to an increase in
circulating GABA levels in the brain. In contrast to serotonin, this relationship
was found to be significant (p-value=0.0471), suggesting that GABA levels in
minnows can be predicted by ethanol exposure.
After long-term exposure to ethanol, minnow GABA and 5-HIAA levels
were found to be significantly lower than the control at lower concentrations but
increased as ethanol concentration increased thereafter (Fig. 4.8). A similar
effect was also seen in GABA levels of minnows exposed to acute ethanol.
Again, at concentrations higher than 0.5% ethanol, these receptors may become
saturated, leading to an increase in these neurotransmitter levels in the brain.
No significant relationships were found between ethanol concentration and
serotonin levels, although a decreasing trend in these levels was observed which
parallels the results from our acute exposure studies. Further, no correlation was
observed between either of the behavioral endpoints and any of the measured
neurotransmitter levels.
Diazepam: Behavior and Brain Chemistry
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After acute exposure to diazepam, there was no statistical significance in
number of entries among concentrations or time-point due to high variability
among replicates. However, there was an obvious increase in number of entries
to the light side by minnows exposed to the two highest concentrations of
diazepam (Fig. 4.9). This finding suggests an anxiolytic effect of diazepam at
higher concentrations. There was a significant difference in number of entries by
minnows exposed to 0, 35, and 75 µg/L diazepam long-term (Fig. 4.10). A large
decrease in entries occurred in minnows exposed to 35 µg/L diazepam, followed
by a slight increase in entries at higher concentrations, resulting in a U-shaped
response. However, no statistical significance existed among time-points for
long-term exposure to diazepam. There were no statistical differences in time
spent in the light for either acute or long-term diazepam exposures so these data
are not shown.
GABA and 5-HIAA levels decreased following acute diazepam exposure
(Fig. 4.11).The correlation between diazepam concentration and 5-HIAA levels
(R2=0.8118) was very strong while a weak negative correlation was found
between diazepam concentration and GABA levels (R2=0.2759) (Table 4.2).
There was also a significant increase in serotonin at the lowest concentration of
diazepam followed by a decrease back to control levels.
After long-term exposure to diazepam, both serotonin and 5-HIAA levels
significantly decreased at 75 µg/L, but levels subsequently increased at the
highest concentration (Fig. 4.12). In contrast, there were significantly higher
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GABA levels in exposed minnows at lower concentrations with a subsequent
decrease at higher concentrations. There were no strong correlations observed
between long-term diazepam exposure and neurotransmitter concentrations. For
both acute and long-term exposures, the neurotransmitter found at the highest
concentrations was 5-HIAA followed by serotonin and GABA.
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Figure 4.9 Number of entries by minnows to the light side of the tank after acute
(1 d) exposure to diazepam. Control = 0 µg/L, Low = 35 µg/L, Medium = 75 µg/L,
High = 150 µg/L. Error bars represent ±1 standard error. Capital letters
represent statistical differences among time-points. Lowercase letters across the
top represent statistical differences among concentrations.
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Figure 4.10 Number of entries by minnows to the light side of the tank after longterm (9 d) exposure to diazepam. Control = 0 µg/L, Low = 35 µg/L, Medium = 75
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Figure 4.11 Minnow neurotransmitter concentrations after acute (1 d) exposure
to 35, 75, and 150 µg/L diazepam. Brains were extracted one day after exposure.
Error bars represent ±1 standard error. Asterisks represent significant difference
from the control. Equations and correlation coefficients are shown above and
next to their respective lines. p GABA=0.0730 and p 5-HIAA=0.1581.
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Figure 4.12 Minnow neurotransmitter concentrations after long-term (9 d)
exposure to 35, 75, and 150 µg/L diazepam. Brains were extracted ten days after
exposure. Error bars represent ±1 standard error. Asterisks represent significant
difference from the control.
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Table 4.2 P-values and R2 values for neurotransmitter regression lines after
acute exposure to diazepam.

Neurotransmitter

P-value

R2 value

GABA

0.0730

0.2759

5-HT

Not shown

Not shown

5-HIAA

0.1581

0.8118

After acute exposure to diazepam, there was an obvious increase in
number of entries to the light side by minnows at 75 µg/L which continued in the
150 µg/L exposed minnows, suggesting an anxiolytic effect of diazepam on
minnow behavior (Fig. 4.9). A threshold effect could explain why only at 75 μ/L
and above, I found an anxiolytic effect of diazepam on minnow behavior.
Previous literature supports this finding of an anxiolytic response in that after
exposure to GABA-enhancing drugs like diazepam, rodents and zebrafish
displayed anxiolytic behaviors38.
There was a significant difference in number of entries by minnows
exposed to 0, 35, and 75 µg/L diazepam for nine days (Fig 4.10). A large
decrease in entries occurred in minnows exposed to 35 µg/L diazepam, followed
by a slight increase in entries at higher concentrations, suggesting an anxiolytic
effect of diazepam exposure on a long-term scale on minnow locomotion at
higher concentrations. Similar results were observed in a study that subjected
zebrafish to the novel tank diving test after exposure to diazepam. More time
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spent on the bottom of the tank is indicative of increased anxiety. Although this
study used higher concentrations of diazepam (from 0.625 to 20 mg/L), they
observed a U-shaped dose effect on bottom dwelling in zebrafish66. Low and
high concentrations as well as the middle concentration did not have an
anxiolytic effect on bottom dwelling, but moderate concentrations did66. Our
results parallel their finding in that a U-shaped dose effect was also observed,
but with a decrease in entries by control minnows compared to 35 μg/L exposed
minnows followed by an increase in entries at higher concentrations.
Acute diazepam exposure resulted in significant decreases in both 5-HIAA
and GABA (Fig. 4.11). A strong negative correlation was observed between
diazepam concentration and 5-HIAA levels (R2=0.8118) while a weak negative
correlation was found between diazepam concentration and GABA levels
(R2=0.2759) (Table 4.2). Diazepam is a positive allosteric modulator of GABA
type A (GABAA) receptors. Binding of diazepam to these receptors promotes the
binding of GABA and GABA-enhancing effects. The enhancement of the GABAergic system has been shown to induce anxiolytic effects in several species by
inhibiting all other neurotransmitters38.
After a longer exposure to diazepam, both serotonin and 5-HIAA levels
significantly decreased at 75 µg/L, but levels increased in minnows exposed to
the highest concentration (Fig. 4.12). In contrast, there were significantly higher
GABA levels in exposed minnows than in control minnows at lower
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concentrations of diazepam, but a subsequent decrease in GABA levels at higher
concentrations, although this decrease was not significant. Because of a lack of
strong correlations observed between long-term diazepam exposure and
neurotransmitter concentrations, I speculate that long-term exposure to
diazepam may not have much of an effect on GABA levels in the brain. This
relationship provides more insight to the interaction between diazepam and the
GABA-ergic system.
My study is the only one in the literature that measured neurotransmitter
levels after exposure to diazepam. Thus, it can begin to fill the gap in the area of
altered brain chemistry after exposure to anxiolytics. Further, significant
correlations were observed between both behavioral endpoints and measured
neurotransmitter levels, discussed below.
Buspirone: Behavioral and Brain Chemistry

After exposure to acute buspirone, there was no statistical significance
among concentrations for number of entries and no apparent trends among
timepoints either (Fig. 4.13). After long-term exposure to buspirone, there was
no statistical significance among concentrations or time-points for number of
entries due to high variability among replicates. However, there was a noticeable
trend of more entries to the light side of the tank at lower concentrations
compared to higher concentrations (Fig. 4.14).

59

Minnows subjected to an acute exposure to buspirone spent significantly
more time on the light side of the tank compared to control minnows (Fig. 4.15).
This anxiolytic effect of buspirone was immediately apparent. There was also a
significant increase in the amount of time that minnows spent on the light side at
time-points after 0.5 hours, again suggestive of an anxiolytic effect at higher
concentrations.
More definitive results were seen after long-term exposure to buspirone.
There was a statistically significant decrease in the time that minnows spent in
the light when compared to control minnows, except in minnows exposed to 75
µg/L buspirone at the Day 0 time-point (Fig. 4.16). These results suggest a
depressive effect of buspirone upon longer exposure.
After acute exposure to buspirone, there was a dose-dependent decrease
in serotonin, with an R2 value of 0.7079 (Fig. 4.17 and Table 4.3). Minnows
exposed to the higher concentrations of buspirone had significantly lower levels
of serotonin than control minnows. In contrast, 5-HIAA levels increased with a
peak at 75 µg/L buspirone followed by a return to control levels at 150 µg/L.
Long-term exposure to buspirone yielded a dose-dependent increase in GABA,
with an R2 value of 0.7997 (Fig. 4.18 and Table 4.4). There were no significant
differences in measured serotonin or 5-HIAA levels when compared to controls.
After both acute and long-term exposure to buspirone, 5-HIAA was the
neurotransmitter with the highest levels in the brain followed by serotonin and
GABA.
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Figure 4.13 Number of entries by minnows to the light side of the tank after
acute (1 d) exposure to buspirone. Control = 0 µg/L, Low = 35 µg/L, Medium =
75 µg/L, High = 150 µg/L. Error bars represent ±1 standard error. Capital letters
represent statistical differences among time-points. Lowercase letters across the
top represent statistical differences among concentrations.
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Figure 4.14 Number of entries by minnows to the light side of the tank after longterm (9 d) exposure to buspirone. Control = 0 µg/L, Low = 35 µg/L, Medium = 75
µg/L, High = 150 µg/L. Error bars represent ±1 standard error. Capital letters
represent statistical differences among time-points. Lowercase letters across the
top represent statistical differences among concentrations.
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Figure 4.15 Time spent in light by minnows after acute (1 d) exposure to
buspirone. Control = 0 µg/L, Low = 35 µg/L, Medium = 75 µg/L, High = 150 µg/L.
Error bars represent ±1 standard error. Capital letters represent statistical
differences among time-points. Lowercase letters across the top represent
statistical differences among concentrations.
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Figure 4.16 Time spent in light by minnows after long-term (9 d) exposure to
buspirone. Control = 0 µg/L, Low = 35 µg/L, Medium = 75 µg/L, High = 150 µg/L.
Error bars represent ±1 standard error. Capital letters represent statistical
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statistical differences among concentrations.
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Figure 4.17 Minnow neurotransmitter concentrations after acute (1 d) exposure
to 35, 75, and 150 µg/L buspirone. Brains were extracted one day after exposure.
Error bars represent ±1 standard error. Asterisks represent significant difference
from the control.
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Figure 4.18 Minnow neurotransmitter concentrations after long-term (9 d)
exposure to 35, 75, and 150 µg/L buspirone. Brains were extracted ten days after
exposure. Error bars represent ±1 standard error. Asterisks represent significant
difference from the control. Equation and correlation coefficient are shown next
to their respective line. p GABA=0.4098.
Table 4.3 P-values and R2 values for neurotransmitter regression lines after
acute exposure to buspirone.

Neurotransmitter

P-value

R2 value

GABA

Not shown

Not shown

5-HT

0.3941

0.7079

5-HIAA

Not shown

Not shown
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Table 4.4 P-values and R2 values for neurotransmitter regression lines after longterm exposure to buspirone.

Neurotransmitter

P-value

R2 value

GABA

0.4098

0.7997

5-HT

Not shown

Not shown

5-HIAA

Not shown

Not shown

After exposure to acute buspirone, I found no statistical significance
among concentrations for number of entries (Fig. 4.13). These results parallel
another study in which zebrafish were injected with buspirone and researchers
found no observable effect of buspirone dose on locomotion41.
After exposure to long-term buspirone, there was no statistical significance
among concentrations or time-points for number of entries (Fig. 4.14). However,
there does seem to be a noticeable trend present. There were more entries at
lower concentrations as compared to higher concentrations. Although not
significant due to high variability among replicates, the observation suggests that
at lower concentrations, long-term exposure to buspirone had an anxiolytic effect
on minnows. As concentrations increased, minnows were less active and less
willing to explore the tank. Alternatively, minnows could become tolerant to
buspirone at higher concentrations, and so are not affected by the drug as much
and do not enter the light side as often.
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There was a significant and immediate increase in time spent on the light
side by exposed minnows as compared to control minnows after acute exposure
to buspirone (Fig. 4.15). This observation indicates that minnows were less
anxious to explore the light side of the tank, suggesting that buspirone had an
anxiolytic effect on the minnow’s preference for the light side of the tank.
Maximino et al. found similar results as zebrafish in their experiment exhibited a
dose dependent increase in time spent in the light compartment41. Connors et al.
also found similar results: zebrafish exposed to higher concentrations of
buspirone spent far more time in the white compartment when compared to
minnows exposed to lower concentrations50. My study found a significant
increase in the amount of time that minnows spent on the light side at time-points
after 0.5 hours, again suggestive of an anxiolytic effect of buspirone.
In contrast, after long-term exposure to buspirone, there was a statistically
significant decrease in the time that minnows spent in the light when compared to
control minnows, except in minnows exposed to 75 µg/L buspirone at the Day 0
time-point, where time spent in light increased again (Fig. 4.16). This finding
parallels the entry data after long-term exposure to buspirone discussed above.
Thus, exposure to long-term buspirone may cause a depressive effect in
minnows resulting in less time spent in the light.
As Figure 4.17 shows, a dose-dependent decrease in serotonin levels
after acute exposure to buspirone occurred. An R2 value of 0.7079 indicated that
buspirone exposure is a strong predictor of serotonin levels, although the p-value
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of regression (0.3941) was not significant (Table 4.3). The result was expected
because buspirone is a known serotonin receptor agonist that reduces the
synthesis and release of serotonin in the brain25. In contrast, a significant
increase in 5-HIAA levels was found in minnows after exposure to 75 µg/L
buspirone. Because 5-HIAA is a metabolite of serotonin, I would expect an
increase in 5-HIAA as serotonin levels decrease.
In contrast to the acute exposure, long-term exposure to buspirone yielded
a dose-dependent increase in measured GABA levels although the change was
not found to be statistically significant (Fig. 4.18 and Table 4.4). Further, no
correlation was observed between either of the behavioral endpoints and any of
the measured neurotransmitter levels. My study is the only one in the literature
that measured neurotransmitter levels after exposure to buspirone, it serves as a
stepping stone for future studies.
Fluoxetine: Behavior and Brain Chemistry

After acute exposure to fluoxetine, minnows entered the light side of the
exposure tank more than control minnows. The trend was most obvious at 0.5
and 24 hours after exposure (Fig. 4.19). While high variability among replicates
reduced statistical power, a dose-related decrease in entries to the light side of
the tank is apparent.
After acute exposure to 35 µg/L fluoxetine, minnows spent less time on
the light side of the tank than control minnows (Fig. 4.20). The time spent in the
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light for minnows exposed to 35 µg/L fluoxetine was statistically less than that of
all other minnows. At concentrations higher than 35 µg/L fluoxetine, the time
spent in the light increased to that of control minnows. Differences in time spent
in the light at each time-point were not significant. After long-term exposure to
fluoxetine, there were no statistical differences in either behavioral measure, and
so those data are not shown.
Acute exposure to 35 µg/L fluoxetine significantly decreased GABA levels
in minnows (Fig. 4.21). However, these levels were increased after exposure to
a higher concentration of fluoxetine. The same positive trend was observed in
serotonin and 5-HIAA levels. Minnows exposed to 35 μg/L fluoxetine on a longterm scale had significantly decreased serotonin levels (Fig. 4.22). However,
these levels significantly increased after exposure to 75 μg/L and remained
higher than control minnow serotonin levels after exposure to150 μg/L. Again,
the same positive trend was observed with GABA and 5-HIAA levels, results that
paralleled what I observed in the acute exposures. Following both acute and
long-term exposure to fluoxetine, serotonin was found in the highest quantity
followed by 5-HIAA and GABA.
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Figure 4.19 Number of entries by minnows to the light side of the tank after
acute (1 d) exposure to fluoxetine. Control = 0 µg/L, Low = 35 µg/L, Medium =
75 µg/L, High = 150 µg/L. Error bars represent ±1 standard error. Capital letters
represent statistical differences among time-points. Lowercase letters across the
top represent statistical differences among concentrations.
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Figure 4.20 Time spent in light by minnows after acute (1 d) exposure to
fluoxetine. Control = 0 µg/L, Low = 35 µg/L, Medium = 75 µg/L, High = 150 µg/L.
Error bars represent ±1 standard error. Capital letters represent statistical
differences among time-points. Lowercase letters across the top represent
statistical differences among concentrations.
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Figure 4.21 Minnow neurotransmitter concentrations after acute (1 d) exposure
to 35, 75, and 150 µg/L fluoxetine. Brains were extracted one day after exposure.
Error bars represent ±1 standard error. Asterisks represent significant difference
from the control.
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Figure 4.22 Minnow neurotransmitter concentrations after long-term (9 d)
exposure to 35, 75, and 150 µg/L fluoxetine. Brains were extracted one day after
exposure. Error bars represent ±1 standard error. Asterisks represent significant
difference from the control.
Fluoxetine is one of the most studied medications in terms of its effect on
organism behavior as evidenced by the plethora of research in the past
decade37,38,41,45,55. The conclusion from the majority of the research is that
exposure to fluoxetine causes anxiolytic effects in fish. One of these studies
exposed zebrafish to 100 μg/L fluoxetine for 2 weeks and observed their
behavior in the novel tank diving test45. Fluoxetine was shown to cause robust
anxiolytic effects in the zebrafish, including increased exploration and reduced
erratic movements45. A second experiment subjected zebrafish to the light-dark
scototaxis test after injection with either 5 or 10 mg/kg fluoxetine41. Researchers
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observed altered locomotion and more time spent in the light compartment by
zebrafish at the highest dose after chronic injection with fluoxetine41. However,
fluoxetine was found to have no effect on zebrafish behavior after 20 minutes of
exposure38.
After acute exposure to fluoxetine, we observed that minnows entered the
light side of the exposure tank more than control minnows (Fig. 4.19). The trend
was most apparent at 0.5 and 24 hours after exposure, although it was not found
to be statistically significant due to high variability among replicates. These
results parallel previous studies that observed anxiolytic behaviors in zebrafish
after fluoxetine treatment. However, at higher concentrations of fluoxetine, a
decrease in entries was observed. As Figure 4.20 depicts, after acute exposure
to 35 µg/L fluoxetine, minnows spent significantly less time on the light side of the
tank than control minnows. At concentrations higher than 35 µg/L fluoxetine, the
time spent in the light increased to that of control minnows.
In contrast with previous studies, I found a decreasing trend in anxiolytic
behaviors, specifically minnow entries, after exposure. These differences
between my research and previous research could be explained by species
differences, differences in route of exposure, and differences in the duration of
exposure and observation periods. Previous studies exposed zebrafish to
fluoxetine for a shorter period of time than my study as well as observed them for
a shorter period of time. A shorter exposure and observation period would
explain why I observed an anxiolytic effect at the beginning of the experiment
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followed by a decrease in entries over the course of the experiment. In addition,
injection of the drug is a faster route of exposure than simple waterborne
immersion and thus, the effects of the drug would manifest themselves more
rapidly after injection.
I did not find any significant effects of long-term fluoxetine treatment on
minnow anxiety behavior although several past studies have documented an
anxiolytic effect after two weeks of fluoxetine treatment45. Again, the difference
could be attributed to species differences as well as differences in route of
exposure and duration of exposure/observation periods.
After acute exposure to fluoxetine, neurotransmitters reached their
maximum level at 75 µg/L and subsequently decreased to levels similar to those
of controls (Fig. 4.21). These results do not parallel previous results from our lab
or other studies performed as I observed an increase in all neurotransmitter
concentrations when compared to the controls. After exposure to the other
compounds in my study, there were observable decreases in brain
neurotransmitter concentrations. A previous study also reported decreased
serotonin levels in hybrid striped bass after exposure to the same concentrations
of fluoxetine for six days37. The most obvious difference between the conflicting
results is the species of fish used. It may be that fathead minnows respond
differently to fluoxetine exposure compared to larger fish species such as the
hybrid striped bass.
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As depicted in Figure 4.22, minnows exposed to 35 μg/L fluoxetine on a
long-term scale had significantly decreased serotonin levels. However, these
levels significantly increased after exposure to higher concentrations of fluoxetine
and remained higher than control levels at the highest concentration. The same
trend was observed with GABA and 5-HIAA levels and also, paralleled what I
observed after acute exposure to fluoxetine. After chronic treatment with SSRIs,
antidepressant effects such as a rise in serotonin levels have been reported71,72
which could explain my observations of increased neurotransmitter levels in
minnow brains as minnows were exposed to fluoxetine for nine days, much
longer than previous literature reports. Moreover, despite increases in all
neurotransmitters, serotonin levels were most affected by fluoxetine treatment
which was expected as fluoxetine is a known SSRI. Further, no correlation was
observed between either of the behavioral endpoints and any of the measured
neurotransmitter levels.
Copper: Behavioral and Brain Chemistry
After acute exposure to copper, there was an increasing trend in entries to
the light side of the tank at and above 40 µg/L (Fig. 4.23). However, due to high
variability among replicates, the trend was not statistically significant. Minnows
exposed to these concentrations entered the light side more than control
minnows and those minnows exposed to the lowest concentration of copper.
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Moreover, in regards to time spent in the light, there was a significant difference
among time-points, specifically 12 and 24 hours after exposure (Fig. 4.24).
There were no statistical differences in the long-term exposures in either
number of entries or time spent in the light. Thus, I conclude that copper does
not have a long-term effect on fathead minnow anxiety behavior. My study, as
far as I know, is the only study to investigate the effects of copper exposure, both
on an acute and long-term scale, on anxiety behavior in fathead minnows.
A strong negative correlation was found between copper concentration
and all neurotransmitter levels after an acute exposure (Fig. 4.25). 5-HIAA levels
were significantly decreased at 20 µ/L, GABA levels at 20 µg/L, and serotonin
levels at the highest concentration, which was 80 µg/L. The neurotransmitter
found in the highest quantity was 5-HIAA followed by serotonin and GABA. After
long-term exposure to copper, however, only GABA and serotonin levels were
significantly decreased when compared to controls (Fig. 4.26). Moreover, a
strong negative correlation was found between copper concentration and
serotonin and GABA concentrations (R2=0.7257 and 0.9645, respectively) (Table
4.6). The relationship between serotonin levels and copper concentration was
found to be statistically significant (p=0.0311).
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Figure 4.23 Number of entries by minnows to the light side of the tank after
acute (1 d) exposure to copper. Control = 0 µg/L, Low = 20 µg/L, Medium = 40
µg/L, High = 80 µg/L. Error bars represent ±1 standard error. Capital letters
represent statistical differences among time-points. Lowercase letters across the
top represent statistical differences among concentrations.
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Figure 4.24 Time spent in light by minnows after acute (1 d) exposure to copper.
Control = 0 µg/L, Low = 20 µg/L, Medium = 40 µg/L, High = 80 µg/L. Error bars
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differences among concentrations.
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Figure 4.25 Minnow neurotransmitter concentrations after acute (1 d) exposure
to 20, 40, and 80 µg/L copper. Brains were extracted one day after exposure.
Error bars represent ±1 standard error. Asterisks represent significant difference
from the control. Equations and correlation coefficients are shown above and
below their respective lines. p GABA=0.1111, p 5-HT=0.5598, p 5-HIAA=0.1088.
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Figure 4.26 Minnow neurotransmitter concentrations after long-term (9 d)
exposure to 20, 40, and 80 µ/L copper. Brains were extracted ten days after
exposure. Error bars represent ±1 standard error. Asterisks represent significant
difference from the control. Equations and correlation coefficients are shown
above and next to their respective lines. p GABA=0.5390, p 5-HT=0.0311, p 5HIAA=0.1921.
Table 4.5 P-values and R2 values for neurotransmitter regression lines after
acute exposure to copper.

Neurotransmitter

P-value

R2 value

GABA

0.1111

0.7393

5-HT

0.5598

0.7569

5-HIAA

0.1088

0.4624

81

Table 4.6 P-values and R2 values for neurotransmitter regression lines after longterm exposure to copper.

Neurotransmitter

P-value

R2 value

GABA

0.5390

0.9645

5-HT

0.0311

0.7257

5-HIAA

0.1921

0.3259

After acute exposure to copper, there was an increasing trend in entries to
the light side of the tank in minnows exposed to higher concentrations of copper
(Fig. 4.23). Minnows exposed to lower concentrations of copper entered the light
side of the tank less often than those minnows exposed to higher concentrations.
A proposed mode of action for copper is interference with the olfactory sensory
neurons that are embedded in fish epithelial tissue32. This interference can
cause alterations in predator avoidance behavior of prey so that prey fish cannot
sense that a predator is near and has been shown to alter fish preference for the
light or dark side in behavioral testing33. If the olfactory sense is affected
negatively by copper, fish may behave differently and enter the environment that,
innately, they do not prefer, possibly making them susceptible to a predator.
In addition, my results support the conclusion of a threshold of copper at
40 μg/L such that until this critical concentration is reached, fish prefer the dark
side of the tank. Moreover, in regards to time spent in the light, there was a
significant difference among time-points, specifically 12 and 24 hours after
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exposure. Exposed minnows spent more time on the light side of the tank after
the 24 hr time-point than the 12 hr time-point (Fig. 4.24), suggesting a threshold
of exposure time as well.
As depicted in Figure 4.25, a strong negative correlation was found
between copper concentration and neurotransmitter levels. 5-HIAA levels were
significantly decreased at 20 µ/L, GABA levels at 20 µg/L, and serotonin levels at
the highest concentration, 80 µg/L, with R2 values of 0.4624, 0.7393, and 0.7569
for 5-HIAA, GABA, and serotonin, respectively (Table 4.5). Thus it seems that
copper concentration would be a good predictor of brain neurotransmitter levels.
These results were expected because it has been proposed that copper affects
both the HPA access and serotonin metabolism in the brain by causing crosslinking between molecules34,70. These decreased neurotransmitter levels may
cause differences in fish behavior, leaving them more susceptible to predation.
After long-term exposure to copper, significant decreases were seen in
serotonin levels of exposed minnows (Fig. 4.26). Moreover, GABA levels in
exposed minnows also decreased relative to controls. A strong negative
correlation was observed between long-term exposure to copper and
neurotransmitter concentrations, specifically serotonin and GABA (R2=0.7257
and 0.9645, respectively) (Table 4.6). These correlation coefficients suggest that
copper concentration is a good predictor of serotonin and GABA levels in the
brain on a long-term scale. Additionally, I found a significant linear relationship
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between copper concentration and serotonin levels (p=0.0311) which adds to my
conclusion that exposure to copper on a long-term scale decreases serotonin
levels in minnow brains.
My long-term results parallel a previous study that exposed juvenile carp
to sub-lethal levels of copper for one week28. Researchers observed a dosedependent decrease in serotonin levels in three different parts of the brain: the
hypothalamus, the tencephalon, and the brain stem. In addition, they observed
no significant changes in 5-HIAA28, also parallel to my study, where the R2 value
for 5-HIAA levels versus copper concentration was 0.2119. Thus, I conclude that
long-term copper concentration does not affect 5-HIAA levels in the brain, and is
not a good predictor of this endpoint. Because 5-HIAA levels were found to be
decreased after acute exposure to copper, but fluctuated after long-term
exposure, I speculate that these receptors become tolerant, and thus, copper
does not have as much of an effect in the long-term. Further, no correlation was
observed between either of the behavioral endpoints and any of the measured
neurotransmitter levels.
Linking Behavior with Brain Chemistry
When plotted on a log-log plot, there was a strong negative relationship
between both number of entries into the light side and the time spent on the light
side of the tank and measured GABA concentrations after acute diazepam
exposure. Variability among replicates resulted in p-values that were not
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considered statistically significant (p=0.0635 and 0.0514, respectively).
Nevertheless, an obvious relationship is present. A weak, negative correlation
was observed for both of these relationships with R2 values of 0.148 and 0.1617,
respectively.
When plotted on a log-log plot, there was a significant relationship
between both the number of entries into the light side and the time spent on the
light side of the tank and measured 5-HIAA concentrations after acute diazepam
exposure with p values of 0.0274 and 0.0148, respectively (Figs. 4.29 and 4.30).
A weak, negative correlation was observed for both of these relationships
(R2=0.2023 and 0.2412, respectively).
A significant relationship was observed between both the log number of
entries and log time spent in the light and log [serotonin] after long-term
diazepam exposure (Figs. 4.31 and 4.32). The p-values were 0.0255 and
0.0409, respectively. Both of these positive relationships were found to be
weakly correlated (R2=0.2159 and 0.1843, respectively).
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Figure 4.27 Double log plot of fish behavior (number of entries into the light side
of the tank) as a function of measured GABA concentrations after acute (1 d)
diazepam exposure. The equation and correlation coefficient are depicted.
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Figure 4.28 Double log plot of fish behavior (time spent on the light side of the
tank) as a function of measured GABA concentrations after acute (1 d) diazepam
exposure. The equation and correlation coefficient are depicted. p=0.0514.

4.5
4
Log Number of Entries

3.5
y = -0.6747x + 5.4078
R² = 0.2023

3
2.5
2
1.5
1
0.5
0
4

4.5

5

5.5

6

6.5

7

Log [5-HIAA] (mg/g protein)

Figure 4.29 Double log plot of fish behavior (number of entries into the light side
of the tank) as a function of measured 5-HIAA concentrations after acute (1 d)
diazepam exposure. The equation and correlation coefficient are depicted.
p=0.0274.
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Figure 4.30 Double log plot of fish behavior (time spent on the light side of the
tank) as a function of measured 5-HIAA concentrations after acute (1 d)
diazepam exposure. The equation and correlation coefficient are depicted.
p=0.0148.
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Figure 4.31 Double log plot of fish behavior (number of entries into the light side
of the tank) as a function of measured serotonin (5-HT) concentrations after longterm (9 d) diazepam exposure. The equation and correlation coefficient are
depicted. p=0.0255.
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Figure 4.32 Double log plot of fish behavior (time spent on the light side of the
tank) as a function of measured serotonin (5-HT) concentrations after long-term
(9 d) diazepam exposure. The equation and correlation coefficient are depicted.
p=0.0409.
Exposure to anthropogenic contaminants can result in changes in brain
chemistry that can then affect an organism’s behavior. If this relationship can be
understood, scientists will be able to better predict the effects of these
contaminants on organisms, leading to better management and regulation
practices. However, there have been very few studies that have been able to
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successfully correlate organism behavior with brain chemistry. As brain
chemistry can be used to predict behavior, I plotted minnow behavior in the lightdark behavioral bioassay as a function of neurotransmitter concentration.
Significant relationships were found between both behavioral endpoints
and measured GABA and 5-HIAA concentrations after exposure to acute
diazepam as well as between both behavioral endpoints and measured serotonin
concentrations after exposure to long-term diazepam (Figs. 4.27-4.32).
Diazepam was the only drug where a significant relationship between behavioral
measures and neurotransmitters was observed. Based on previous research,
exposure to these anti-anxiety medications leads to an increase in number of
entries to the light side and time spent on the light side, the two behavioral
endpoints measured41,50. I found that exposure to diazepam resulted in the
display of anxiolytic behaviors by minnows on both an acute and long-term scale
(Figs. 4.9 and 4.10). In addition, exposure to these anti-anxiety medications can
result in a decrease in circulating neurotransmitter levels, specifically those that
regulate stress and anxiety, like serotonin and GABA36,37. Studies investigating
the effect of anti-anxiety medications on GABA, another stress-related
neurotransmitter, are less reported. I observed decreases in levels of three
neurotransmitters after minnows were exposed to diazepam on both an acute
and a long-term scale (Figs. 4.11 and 4.12). Thus, I hypothesized that as
minnow neurotransmitter levels decrease, minnows should enter the light side of
the tank more and spend more time on the light side. I found support for the
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hypothesis in both GABA and 5-HIAA levels after minnows were exposed to
acute diazepam. As GABA and 5-HIAA levels in the brain decreased, minnows
made more entries to the light side as well as spent significantly more time in the
light. However, although the relationship between these measures was found to
be significant in terms of 5-HIAA levels (p= 0.0274 and 0.0148, respectively),
measured GABA and 5-HIAA levels seem to be weak predictors of minnow
entries and time spent in the light, as the respective correlation coefficients
0.148, 0.1617, 0.2023, and 0.2412 suggest. The low correlation coefficients
could be the result of a small sample size as well as the inability to extract brains
at all timepoints, leading to high variability and a lack of a dose-dependent trend
in both the behavioral data as well as the brain data (Figs. 4.9-4.12). In contrast,
I found a weak, positive relationship between both log number of entries and log
time spent in the light and measured serotonin levels after minnows were
exposed to diazepam on a long-term scale. As serotonin levels in the brain
increased, minnows made more entries to the light side as well as spent more
time in the light. These results were the opposite of what was predicted: as
serotonin levels in the brain decrease, minnows should enter the light side of the
tank more and spend more time on the light side. The relationship was
significant despite the low correlation coefficients (R2=0.2159 and 0.1843). Thus,
a change in measured serotonin levels seems to be a weak predictor of minnow
anxiety behavior after long-term exposure to diazepam. Serotonin levels
measured in minnows exposed to the highest concentration of diazepam were

91

higher than control minnows (Fig. 4.12) which could be an explanation as to why
I observed a positive trend between behavioral endpoints and serotonin
concentration rather than the predicted negative trend. As diazepam is known to
enhance the GABA-ergic system, it comes as no surprise that a weak
relationship was found between anxiety behaviors and measured GABA
concentrations. Moreover, the weak relationships that were found between
neurotransmitters involved in the serotonergic system and diazepam may spark
more research on this drug as it has not been suggested that diazepam has any
effect on the serotonergic system.
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CHAPTER 5: CONCLUSIONS AND FUTURE DIRECTIONS
From this research, I can conclude the following:
•

Acute exposure to ethanol, a positive control for this behavioral assay,
results in an anxiolytic effect in minnow behavior and brain chemistry at
the onset of exposure, but a depressing effect as time goes on due to its
nature as a sedative.

•

The most definitive results were observed after exposure to diazepam.
Exposure to this drug will cause an anxiolytic effect on minnow behavior at
high concentrations both acutely (one day) and on a long-term scale (nine
days).

•

Fluoxetine exposure causes an anxiolytic effect in minnow behavior on an
acute time scale, yet results in an overall increase in neurotransmitter
concentrations both acutely and on a long-term scale as is supported by
previous literature.

•

Overall, exposure to anti-anxiety drugs results in a decrease in
neurotransmitter levels that may affect predator avoidance behaviors in
fathead minnows.

•

Acute exposure to copper results in an anxiolytic effect on minnow
behavior and a decrease in neurotransmitter levels as time passes and
exposure concentrations increase.

•

The relationship between behavior and brain chemistry after chemical
exposure can be further developed as evidenced by the significant, but

93

weak relationships that were found between minnow behavior and all
measured neurotransmitter levels after exposure to diazepam.
•

Results from this study combined with further research will lead to better
regulation of contaminants and management of susceptible species.
As stated above, one restriction of the experimental setup was the small

sample size, which led to variability among replicates. A larger sample size
would offer the possibility of lower variability and more significant trends in the
data as well as allow one to tease out the correlation between brain chemistry
and behavior in minnows after exposure to contaminants. A larger sample size
would also allow brains to be extracted and analyzed after every timepoint during
exposure. In addition, the light-dark behavioral bioassay that was used in my
experiments was developed for zebrafish. Future exposures using this assay
should be performed with zebrafish in order to understand some of the possible
species differences. Finally, there is a lack of research concerning the chronic
effect of anti-anxiety medications on aquatic organisms. Future studies should
be aimed at determining the effects of these medications on aquatic organisms
on a long-term scale. Longer exposure times are more relevant as aquatic
organisms are more likely to be exposed to sub-lethal doses of these drugs for
an extended period of time rather than to acute doses. These studies will
provide researchers with additional insight on the fate and metabolism of these
drugs in the aquatic environment. Once scientists know more about how these
drugs may affect aquatic organisms in the long-term, better management
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practices and regulations may be passed for the use and disposal of anti-anxiety
medications and other anthropogenic contaminants, leading to a healthier and
safer environment for humans.
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